Roger Mysliwiec

Dr. Roger Mysliwiec is the director of a New Zealand Eating Disorders Clinic and a prominent voice in discussions surrounding the implications of GLP-1 weight-loss drugs like Ozempic and Wegovy. He has expressed concerns about the aggressive marketing of these medications, particularly on social media, and their potential to exacerbate eating disorders among vulnerable populations. Mysliwiec highlights the need for careful prescription and management of these drugs, emphasizing the risks associated with unregulated use and the alarming trends in weight-loss marketing.